| Literature DB >> 35252276 |
Tai Zhang1,2, Beihua Zhang1,2, Wende Tian1,3, Xiangxue Ma1,2, Fengyun Wang1,2, Ping Wang1,2, Yuchen Wei1,2, Lin Liu1,2, Xudong Tang4.
Abstract
BACKGROUND: Atrophic gastritis (AG), which is characterized by a decreased number or disappearance of the glandular structures and secretory dysfunction, is linked to chronically inflamed stomach. It has been estimated that the annual incidence of gastric cancer (GC) is 0.1% for patients with AG. Early eradication of Helicobacter pylori (H. pylori) can reduce the risk of GC development. Additionally, the follow-up and management of AG are necessary to prevent GC. Exploring novel methods of the automatized analysis of data for apprehending knowledge in any medical field is encouraged, especially when a body of literature suggests the necessity of doing so. Accordingly, herein, we aim to systematically review the current foci and status of AG research using bibliometric analysis.Entities:
Keywords: atrophic gastritis; bibliometric; gastric cancer; hotspots; trends
Year: 2022 PMID: 35252276 PMCID: PMC8891522 DOI: 10.3389/fmed.2022.843395
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
Figure 1Annual output of atrophic gastritis (AG) research.
The top 10 countries or regions and institutions involved in atrophic gastritis (AG) research.
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
| 1 | China | 2011 | 0.02 | 377 (26.32) | Vanderbilt University (USA) | 2011 | 0.24 | 56 (3.91) |
| 2 | USA | 2011 | 0.38 | 272 (18.99) | Seoul National University (Korea) | 2011 | 0.05 | 39 (2.72) |
| 3 | Japan | 2011 | 0.16 | 248 (17.31) | University of Tokyo (Japan) | 2011 | 0.17 | 38 (2.65) |
| 4 | Italy | 2011 | 0.23 | 124 (8.65) | University of Porto (Portugal) | 2011 | 0.08 | 37 (2.58) |
| 5 | South Korea | 2011 | 0.01 | 119 (8.31) | Washington University (USA) | 2011 | 0.07 | 29 (0.20) |
| 6 | Germany | 2011 | 0.07 | 64 (4.46) | China Medical University (China) | 2013 | 0.03 | 29 (0.20) |
| 7 | Turkey | 2011 | 0.00 | 52 (3.63) | University of Padua (Italy) | 2011 | 0.09 | 28 (0.19) |
| 8 | Portugal | 2011 | 0.10 | 51 (3.56) | Baylor College of Medicine (USA) | 2011 | 0.15 | 28 (0.19) |
| 9 | England | 2011 | 0.08 | 40 (2.79) | Oita University (Japan) | 2011 | 0.00 | 24 (0.16) |
| 10 | Iran | 2011 | 0.02 | 35 (2.44) | University of Latvia (Latvia) | 2011 | 0.1 | 21 (0.14) |
Figure 2Network of countries and regions engaged in AG research.
Figure 3Network of institutions engaged in AG research.
The top 10 authors in AG research.
|
|
|
|
|
|---|---|---|---|
| 1 | James R Goldenring | 31 (2.16) | 0.22 |
| 2 | Bruno Annibale | 28 (1.95) | 0.04 |
| 3 | Yuan Yuan | 27 (1.88) | 0.00 |
| 4 | Peter Malfertheiner | 26 (1.81) | 0.04 |
| 5 | Edith Lahner | 25 (1.74) | 0.02 |
| 6 | Marcis Leja | 25 (1.74) | 0.07 |
| 7 | Massimo Rugge | 24 (1.67) | 0.15 |
| 8 | Nayoung Kim | 23 (1.60) | 0.00 |
| 9 | Jason C Mills | 23 (1.60) | 0.13 |
| 10 | Qian Xu | 23 (1.60) | 0.00 |
Figure 4Network of authors in AG research.
Top 10 journals and co-cited journals in AG research.
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
| 1 | WORLD JOURNAL OF GASTROENTEROLOGY (United States) | 62 (4.32) | 5.742 | Q2 | GASTROENTEROLOGY | 997 (69.62) | 22.682 | Q1 |
| 2 | PLOS ONE (United States) | 42 (2.93) | 3.24 | Q3 | GUT | 945 (65.99) | 23.059 | Q1 |
| 3 | HELICOBACTER (England) | 41 (2.86) | 5.753 | Q2 | WORLD JOURNAL OF GASTROENTEROLOGY | 794 (55.44) | 5.742 | Q2 |
| 4 | DIGESTIVE DISEASES AND SCIENCES (United States) | 38 (2.65) | 3.199 | Q3 | CANCER REASERCH | 694 (52.50) | 12.701 | Q1 |
| 5 | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (England) | 34 (2.37) | 2.423 | Q4 | The AMERICAN JOURNAL OF GASTROENTEROLOGY | 672 (52.24) | 10.864 | Q1 |
| 6 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (Australia) | 32 (2.23) | 4.029 | Q2 | HELICOBACTER | 668 (48.46) | 5.753 | Q2 |
| 7 | GASTROENTEROLOGY (United States) | 24 (1.67) | 22.682 | Q1 | INTERNATIONAL JOURNAL OF CANCER | 664 (46.92) | 7.396 | Q1 |
| 8 | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (England) | 21 (1.46) | 2.568 | Q4 | THE AMERICAN JOURNAL OF SURGICAL PATHOLOGY | 594 (46.64) | 6.394 | Q1 |
| 9 | DIGESTIVE AND LIVER DISEASE (Italy) | 20 (1.39) | 4.088 | Q3 | DIGESTIVE DISEASES AND SCIENCES | 550 (40.19) | 3.199 | Q3 |
| 10 | INTERNATIONAL JOURNAL OF CANCER (United States) | 20 (1.39) | 7.396 | Q1 | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 543 (33.22) | 2.423 | Q4 |
Figure 5Dual-map overlay of journals related to AG research.
Top 10 co-cited references in AG research.
|
|
|
|
|
|---|---|---|---|
| 1 | Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) | 105 | 2012 |
| 2 | Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | 89 | 2018 |
| 3 | Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019 | 84 | 2019 |
| 4 | Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | 55 | 2015 |
| 5 | Kyoto global consensus report on Helicobacter pylori gastritis | 55 | 2015 |
| 6 | Management of Helicobacter pylori infection–the Maastricht IV/Florence Consensus Report | 51 | 2012 |
| 7 | The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis | 51 | 2010 |
| 8 | Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer | 47 | 2015 |
| 9 | Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | 45 | 2010 |
| 10 | Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication | 43 | 2016 |
Top 5 co-cited references with the highest centrality in AG research.
|
|
|
|
|
|---|---|---|---|
| 1 | Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma | 0.29 | 2014 |
| 2 | The correlation between histological gastritis staging-“OLGA/OLGIM” and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China | 0.25 | 2017 |
| 3 | Precancerous lesions in the stomach: from biology to clinical patient management | 0.24 | 2013 |
| 4 | Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer | 0.24 | 2014 |
| 5 | Individual risk stratification of gastric cancer: evolving concepts and their impact on clinical practice | 0.23 | 2014 |
Figure 6Top 25 references with strong citation bursts in AG research.
Top 20 keywords with the highest count in AG research.
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| 1 | Cancer | 668 | 0.08 | 11 | Management | 129 | 0.01 |
| 2 | 659 | 0.05 | 12 | Serum pepsinogen | 81 | 0.04 | |
| 3 | Risk | 398 | 0.03 | 13 | Inflammation | 73 | 0.04 |
| 4 | Intestinal metaplasia | 349 | 0.01 | 14 | Progression | 70 | 0.03 |
| 5 | Atrophic gastritis | 339 | 0 | 15 | SPEM | 69 | 0.05 |
| 6 | Prevalence | 207 | 0.01 | 16 | Peptic ulcer | 68 | 0.01 |
| 7 | Eradication | 160 | 0.02 | 17 | Epithelial cell | 66 | 0.04 |
| 8 | Classification | 153 | 0.02 | 18 | Pernicious anemia | 66 | 0.03 |
| 9 | Diagnosis | 145 | 0 | 19 | Marker | 65 | 0.06 |
| 10 | Follow up | 134 | 0.02 | 20 | Meta analysis | 57 | 0.06 |
Figure 7Map of keyword clustering with a minimum of 5 occurrences in AG research.
Figure 8Co-occurrence map of AG research keyword cluster analysis.
Figure 9Top 19 keywords with strong citation bursts in AG research.